Top 10 Bioprocess Technology Market – Global Key Players Are Adopting Different Growth Strategies

PUNE, India, 2021-May-27 — /EPR Network/ —

Research Methodologies Followed for This Study:

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global top 10 bioprocess technology market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Expected Revenue Growth:

The global top 10 bioprocess technology market is expected to reach USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% from 2016 to 2021. Rapid growth in pharmaceutical and biotechnology industries, growth in the number of new drug launches, strong trend of R&D in life sciences research, increasing government support for pharmaceutical and biotechnology industries, and rising prevalence of chronic diseases are the key factors driving the growth of this market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30722776

Geographical Growth Scenario:

In 2016, North America accounted for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics, rising spending on R&D by top players in this region. Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The growth of this market is fueled by overall growth in the biopharmaceutical industry, investments by key market players in Asia countries, increasing government support, developments in R&D infrastructure, increasing outsourcing to Asia countries, and growing expertise and academic excellence in Asia.

Key Players:

The prominent players in the top 10 bioprocess technology market include GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

Top 10 bioprocess technology market is dominated by GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Danaher Corporation (U.S.)

GE Healthcare accounted for the largest share of the global top 10 bioprocess technology market in 2015. The company is engaged in drug discovery, patient monitoring systems, medical imaging solutions, performance improvement solutions, information technologies, medical diagnostics, patient monitoring systems, and biopharmaceutical manufacturing technologies. Healthcare Systems, Life Sciences, and Healthcare IT are the major business segments of the company. The company primarily focusing on inorganic growth strategies to maintain its footprint in the market. In accordance with this, in November 2016, GE healthcare has expanded its single-use technology manufacturing facility of their life science business segment, to the biotechnology industry. In August 2016, GE healthcare and Sealed Air (U.S.), entered into extended agreement to deliver new film suitable for use in GE’s full single-use bioprocess portfolio.

Merck Millipore held the second position in the top 10 bioprocess technology market. The company has a strong geographic presence across the globe spanning from North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. The company operates in four business segments, namely, Biosciences, Lab Solutions, Process Solutions, and Sigma-Aldrich. These segments offer a wide range of products and technologies such as Chromatography, Sterile Filtration, and Ultrafiltration (UF). In order to maintain its position in the market, the company pursues organic as well as inorganic growth strategies. In 2016, the company launched two products in the bioprocess technology market, namely, Mobius 1000L single-use bioreactor and Mobius Power MIX 2000, a single-use mixing system. In December 2016, Merck extended their distribution agreement with Roche (Switzerland) under this extended agreement Merck has incorporated new products to Roche’s distribution product portfolio. This agreement enhanced Merck’s existing distribution relationship with Roche.

Other prominent players in the top 10 bioprocess technology market include Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

An analysis of the market developments between 2014 and 2016 revealed that product launches and agreements & collaborations was the most important growth strategy adopted by market leaders.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=30722776

Target audience for this report:

• Academic Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Bioprocess Technology Manufacturing Companies
• Contract Research Organizations (CROs)
• Market Research & Consulting Firms

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com